[1] 周明俊, 库洪希, 李振龙,等. 冠心病心绞痛患者血清hs-CRP和BNP水平的变化及临床意义[J]. 湖南师范大学学报(医学版), 2015,12(1):93-95. [2] 陈柏兴, 李向平, 罗曼. 冠心病患者血清尿酸和高敏C反应蛋白浓度变化及其意义[J]. 医学临床研究, 2009, 26(8):1457-1460. [3] 刘铁楠. 冠状动脉粥样硬化程度与血浆BNP和hs-CRP的相关性研究[J]. 中西医结合心脑血管病杂志, 2015, 13(8):1025-1026. [4] 张世田, 唐汉庆, 黄岑汉,等. 氧化应激、炎症与冠状动脉粥样硬化关系的研究进展[J]. 右江医学, 2017, 45(2):235-239. [5] PY Poon, CC Szeto, BC Kwan. Relationship between CRP polymorphism and cardiovascular events in Chinese peritoneal dialysis patients [J]. Clin J Am Soc Nephrol, 2012, 7(2): 304-309. [6] Vitale C,Cerquetani E,Wajngarten M, et al. In patients with coronary artery disease endothelial function is associated with plasma levels of C-reactive protein and is improved by optimal medical therapy [J]. Ital Heart J, 2003, 4(9): 627-632. [7] 周晓斌. 冠心病患者血浆BNP及hs-CRP水平变化与冠状动脉病变程度的关系研究[J]. 河北医学, 2015,21(7):1070-1073. [8] Yildirir A, Acikel S, Ertan C, et al. Effects of lesion complexity on baseline and postprocedural B-type natriuretic peptide levels in patients undergoing percutaneous coronary interventions [J]. Tex Heart Ins J, 2007, 34(3) : 282-289.
2019, Vol. 36 
